Call us or book online to get your consultation scheduled in Johnson City
The benefit profile is real, but the magnitude is typically modest compared to modern combination therapies
The second was a matched cohort of 30,528 women, pairing each GLP-1 user with a nonuser who shared similar characteristics, including age, race, ethnicity, BMI, breast density, and diabetes status
Nanofat, on the other hand, has been micronized and enriched, like platelet-rich plasma, to eliminate living cells and acts more like a biostimulatory matrix to improve skin quality and address sub cutaneous fat loss. For patients taking GLP-1 drugs, autologous fat transfer is Rameshs go-to choice for volume restoration
Semaglutide is a GLP-1 receptor agonist initially developed as a medication for diabetes